← SynDRA
PIPOBROMAN
SynDRA canonical compound SYN0011768 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | DNA alkylating agent |
|---|
| Indication | polycythemia vera | thrombocythemia |
|---|
| Disease area | hematology |
|---|
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- CYP3A4
- HDAC6
- HPGD
- HSD17B10
- KAT2A
- KDM4E
- LMNA
- SLCO1B1
- SLCO1B3
- TDP1
- USP2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Alkylating Agents
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- Noxae
ATC classes
Cross-references
Synonyms
- VERCYTE
- amedel
- vercyte
- A-8103
- NSC-25154
- Vercyte
- Amedel
- Pipobromanum
- A 1803
- Pipobroman [USAN:INN]
- Pipobromanum [INN-Latin]
- VERCYTE (TN)
- Pipobroman (JAN/USAN/INN)
- N,N'-Bis(3-bromopropionyl)piperazine
- N,N-Bis-(3-bromopropionyl)-piperazine
- 1,4-Bis(3-bromopropanoyl)piperazine
- 1,4-Bis(3-bromopropionyl)piperazine
- A 8103
- NSC 25154
- NSC25154
- Piperazine, 1,4-bis(3-bromopropionyl)-
- 6Q99RDT97R
- CHEBI:8242
- DTXCID503485
- RefChem:57594
- MFCD00866372
- NCGC00095048-01
- C10H16Br2N2O2
- CAS-54-91-1
- CCRIS 2753
- HSDB 3249
- SR-05000001858
- BRN 0749866
- UNII-6Q99RDT97R
- Pipobroman [USAN:USP:INN]
- AI3-50113
- NJBFOOCLYDNZJN-UHFFFAOYSA-N
- Spectrum_001727
Look up PIPOBROMAN in the interactive SynDRA portal →